These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A pilot study of AL-449 in chronic schizophrenic patients. Sugerman AA. Curr Ther Res Clin Exp; 1968 Oct; 10(10):533-6. PubMed ID: 4971469 [No Abstract] [Full Text] [Related]
8. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients. Amin MM, Brahm E, Ban TA, Lehmann HE. Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753 [No Abstract] [Full Text] [Related]
9. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses]. Vinci M. Osp Psichiatr; 1971 Jul; 39(2):399-407. PubMed ID: 4948707 [No Abstract] [Full Text] [Related]
10. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients. Gallant DM, Bishop MP. Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346 [No Abstract] [Full Text] [Related]
11. A pilot study of AL-1021 in chronic schizophrenic patients. Sugerman AA. Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042 [No Abstract] [Full Text] [Related]
12. A controlled study of the effects of gamfexine in phenothiazine-treated patients. Zimmermann RL, Vestre ND, Schiele BC, Curran J. Curr Ther Res Clin Exp; 1970 Apr; 12(4):230-3. PubMed ID: 4985944 [No Abstract] [Full Text] [Related]
13. [Buronil (FG 5111)--a new butyrophenone derivative. A controlled clinical study on senile dementia and confusion]. Simmelsgaard H, Mellergaard M, Vangtorp A. Nord Med; 1967 Feb 16; 77(7):210-3. PubMed ID: 5336427 [No Abstract] [Full Text] [Related]
14. Combined treatment with ECT and antipsychotic drugs in schizophrenia. Weinstein MR, Fischer A. Dis Nerv Syst; 1971 Dec 16; 32(12):801-8. PubMed ID: 5139202 [No Abstract] [Full Text] [Related]
15. A standard-controlled clinical study with propericiazine in schizophrenic patients. Ananth JV, Ban TA. Psychopharmacol Bull; 1977 Jul 16; 13(3):19-20. PubMed ID: 18754 [No Abstract] [Full Text] [Related]
16. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial. Vinar O, Formánková M, Taussigová D, Růzicka S. Act Nerv Super (Praha); 1967 Nov 16; 9(4):353-5. PubMed ID: 4889058 [No Abstract] [Full Text] [Related]
17. [Clinical evaluation of some butyrophenone derivatives]. Bizoń E, Kakolewski J, Lewicka-Wysocka H. Neurol Neurochir Psychiatr Pol; 1965 Nov 16; 15(6):889-92. PubMed ID: 5324994 [No Abstract] [Full Text] [Related]
18. Controlled study of BL-KR140 on chronic anergic schizophrenic patients stabilized with a neuroleptic compound. Dim BH, Kurland AA. Curr Ther Res Clin Exp; 1968 Jun 16; 10(6):288-91. PubMed ID: 4969835 [No Abstract] [Full Text] [Related]
19. Management of the schizophrenic patient in a community psychiatric practice. Tobin JM. Dis Nerv Syst; 1968 May 16; 29(5):Suppl:27-34. PubMed ID: 4876987 [No Abstract] [Full Text] [Related]
20. [Behavior of some blood serum enzymes in the course of treatment with neuroleptics]. Warnecka-Przybylska M, Szymańska H. Psychiatr Pol; 1969 May 16; 3(2):125-31. PubMed ID: 5802333 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]